{
  "symbol": "MDLZ",
  "year": 2022,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.1261,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.132
  },
  "top_positive": [
    {
      "sent": "dollars, except per share data) (Unaudited) Mondel\u0113z International Shareholders\u2019 Equity Common Stock Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Earnings/ (Losses) Treasury Stock Non-controlling Interest Total Equity Three Months Ended September 30, 2022 Balances at July 1, 2022 $ \u2014 $ 32,086 $ 31,431 $ ( 10,638 ) $ ( 25,368 ) $ 42 $ 27,553 Comprehensive earnings/(losses): Net earnings \u2014 \u2014 532 \u2014 \u2014 1 533 Other comprehensive earnings/(losses), net of income taxes \u2014 \u2014 \u2014 ( 593 ) \u2014 ( 12 ) ( 605 ) Exercise of stock options and issuance of other stock awards \u2014 30 ( 2 ) \u2014 25 \u2014 53 Common Stock repurchased \u2014 \u2014 \u2014 \u2014 ( 338 ) \u2014 ( 338 ) Cash dividends declared ($ 0.390 per share) \u2014 \u2014 ( 524 ) \u2014 \u2014 \u2014 ( 524 ) Dividends paid on noncontrolling interest and other activities \u2014 \u2014 \u2014 \u2014 \u2014 ( 2 ) ( 2 ) Balances at September 30, 2022 $ \u2014 $ 32,116 $ 31,437 $ ( 11,231 ) $ ( 25,681 ) $ 29 $ 26,670 Nine Months Ended September 30, 2022 Balances at January 1, 2022 $ \u2014 $ 32,097 $ 30,806 $ ( 10,624 ) $ ( 24,010 ) $ 54 $ 28,323 Comprehensive earnings/(losses): Net earnings \u2014 \u2014 2,134 \u2014 \u2014 8 2,142 Other comprehensive earnings/(losses), net of income taxes \u2014 \u2014 \u2014 ( 607 ) \u2014 ( 27 ) ( 634 ) Exercise of stock options and issuance of other stock awards \u2014 19 ( 13 ) \u2014 172 \u2014 178 Common Stock repurchased \u2014 \u2014 \u2014 \u2014 ( 1,843 ) \u2014 ( 1,843 ) Cash dividends declared ($ 1.090 per share) \u2014 \u2014 ( 1,493 ) \u2014 \u2014 \u2014 ( 1,493 ) Dividends paid on noncontrolling interest and other activities \u2014 \u2014 3 \u2014 \u2014 ( 6 ) ( 3 ) Balances at September 30, 2022 $ \u2014 $ 32,116 $ 31,437 $ ( 11,231 ) $ ( 25,681 ) $ 29 $ 26,670 Three Months Ended September 30, 2021 Balances at July 1, 2021 $ \u2014 $ 32,042 $ 29,538 $ ( 10,572 ) $ ( 23,465 ) $ 77 $ 27,620 Comprehensive earnings/(losses): Net earnings \u2014 \u2014 1,258 \u2014 \u2014 4 1,262 Other comprehensive earnings/(losses), net of income taxes \u2014 \u2014 \u2014 ( 332 ) \u2014 ( 5 ) ( 337 ) Exercise of stock options and issuance of other stock awards \u2014 24 ( 3 ) \u2014 22 \u2014 43 Common Stock repurchased \u2014 \u2014 \u2014 \u2014 ( 326 ) \u2014 ( 326 ) Cash dividends declared ($ 0.315 per share) \u2014 \u2014 ( 489 ) \u2014 \u2014 \u2014 ( 489 ) Dividends paid on noncontrolling interest and other activities \u2014 \u2014 1 \u2014 \u2014 ( 20 ) ( 19 ) Balances at September 30, 2021 $ \u2014 $ 32,066 $ 30,305 $ ( 10,904 ) $ ( 23,769 ) $ 56 $ 27,754 Nine Months Ended September 30, 2021 Balances at January 1, 2021 $ \u2014 $ 32,070 $ 28,402 $ ( 10,690 ) $ ( 22,204 ) $ 76 $ 27,654 Comprehensive earnings/(losses): Net earnings \u2014 \u2014 3,297 \u2014 \u2014 12 3,309 Other comprehensive earnings/(losses), net of income taxes \u2014 \u2014 \u2014 ( 214 ) \u2014 ( 12 ) ( 226 ) Exercise of stock options and issuance of other stock awards \u2014 ( 4 ) ( 21 ) \u2014 229 \u2014 204 Common Stock repurchased \u2014 \u2014 \u2014 \u2014 ( 1,794 ) \u2014 ( 1,794 ) Cash dividends declared ($ 0.630 per share) \u2014 \u2014 ( 1,378 ) \u2014 \u2014 \u2014 ( 1,378 ) Dividends paid on noncontrolling interest and other activities \u2014 \u2014 5 \u2014 \u2014 ( 20 ) ( 15 ) Balances at September 30, 2021 \ned and impaired these and other related assets.",
      "score": 0.9917
    },
    {
      "sent": "25 Table of Contents Performance Share Units and Other Stock-Based Awards: Our performance share unit, deferred stock unit and historically granted restricted stock activity is reflected below: Number of Shares Grant\u00a0Date Weighted-Average Fair Value Per Share (3) Weighted-Average Aggregate Fair Value (3) Balance at January 1, 2022 4,668,046 $ 57.04 Annual grant to eligible employees: Feb 24, 2022 Performance share units 806,590 61.87 Deferred stock units 505,090 64.65 Additional shares granted (1) 737,537 Various 60.42 Total shares granted 2,049,217 62.03 $ 127 million Vested (2) ( 1,730,719 ) 55.36 $ 96 million Forfeited ( 398,436 ) 60.66 Balance\u00a0at\u00a0September 30, 2022 4,588,108 59.59 (1) Includes performance share units and deferred stock units.",
      "score": 0.9853
    },
    {
      "sent": "Our stock repurchase activity for each of the three months in the quarter ended September\u00a030, 2022 was: Issuer Purchases of Equity Securities Period Total Number of Shares Purchased (1) Average Price\u00a0Paid per\u00a0Share (1) Total\u00a0Number\u00a0of Shares\u00a0Purchased as Part of Publicly Announced Plans or Programs (2) Approximate\u00a0Dollar\u00a0Value of Shares That May Yet Be Purchased Under the Plans or Programs (2) July 1-31, 2022 2,108,944 $ 61.93 2,105,950 $ 2,019 August 1-31, 2022 1,053,061 64.03 1,049,976 1,952 September 1-30, 2022 2,361,113 59.36 2,356,985 1,812 For\u00a0the\u00a0Quarter Ended September 30, 2022 5,523,118 $ 61.23 5,512,911 (1) The total number of shares purchased (and the average price paid per share) reflects: (i)\u00a0shares purchased pursuant to the repurchase program described in (2)\u00a0below; and (ii)\u00a0shares tendered to us by employees who used shares to exercise options and to pay the related taxes for grants of deferred stock that vested, totaling 2,994 shares, 3,085 shares and 4,128 shares for the fiscal months of July, August and September 2022, respectively.",
      "score": 0.9812
    }
  ],
  "top_negative": [
    {
      "sent": "Important factors that could cause our actual results to differ materially from those described in our forward-looking statements include, but are not limited to, the impact of ongoing or new developments in the war in Ukraine, related current and future sanctions imposed by governments and other authorities, and related impacts on our business, growth, employees, reputation, prospects, financial condition, operating results (including components of our financial results), cash flows and liquidity; global or regional health pandemics or epidemics, including COVID-19; risks from operating globally including in emerging markets, including political, economic and regulatory risks; changes in currency exchange rates, controls and restrictions; volatility of commodity and other input costs and availability of commodities; weakness in economic conditions; weakness in consumer spending; inflation (and related monetary policy actions by governments in response to inflation); pricing actions; tax matters including changes in tax laws and rates, disagreements with taxing authorities and imposition of new taxes; use of information technology and third-party service providers; unanticipated disruptions to our business, such as malware incidents, cyberattacks or \nhe preparation of these financial statements requires the use of estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the periods presented.",
      "score": -0.9565
    },
    {
      "sent": "\u2013 Diluted EPS decreased during the first nine months of 2022, primarily driven by lapping prior-year net gains on equity method transactions, unfavorable year-over-year mark-to-market impacts from currency and commodity derivatives, higher acquisition-related costs, incremental costs incurred due to the war in Ukraine, higher acquisition integration costs and contingent consideration adjustments, higher intangible asset impairment charges, lower net earnings from divestitures and inventory step-up charges incurred in 2022, partially offset by lower Simplify to Grow program costs, an increase in Adjusted EPS, lower negative impacts from enacted tax law changes, lower equity method investee items and lapping the prior-year negative impact from pension participation changes.",
      "score": -0.9442
    },
    {
      "sent": "\u2013 Diluted EPS decreased during the first nine months of 2022, primarily driven by lapping prior-year net gains on equity method transactions, unfavorable year-over-year mark-to-market impacts from currency and commodity derivatives, higher acquisition-related costs, incremental costs incurred due to the war in Ukraine, higher acquisition integration costs and contingent consideration adjustments, higher intangible asset impairment charges, lower net earnings from divestitures and inventory step-up charges incurred in 2022, partially offset by lower Simplify to Grow program costs, an increase in Adjusted EPS, lower negative impacts from enacted tax law changes, lower equity method investee items and lapping the prior-year negative impact from pension participation changes.",
      "score": -0.9442
    }
  ],
  "forward_snippets": [
    "We continue to consolidate both our Ukrainian and Russian subsidiaries and continue to evaluate our ability to control our operating activities and businesses on an ongoing basis.",
    "We base our estimates on historical experience, expectations of future impacts and other assumptions that we believe are reasonable.",
    "We continue to monitor the developments in Ukraine and Russia and the COVID-19 global pandemic and related impacts to our business operations, currencies and net monetary exposures.",
    "At this time, within our consolidated entities, Argentina and T\u00fcrkiye are highly inflationary economies as noted above, and we continue to monitor currency volatility and associated risks, such as increased risk of highly inflationary economies and related accounting.",
    "We continue to consolidate both our Ukrainian and Russian subsidiaries and continue to evaluate our ability to control our operating activities and businesses on an ongoing basis."
  ]
}